Using the GEPIA database to analyze the prognostic value of CHRNA5 in HCC, we found that HCC patients with a higher mRNA expression level of CHRNA5 exhibited poorer disease-free survival and overall survival after surgery (Figure 1E,F). This evidence concerns the gene CHRNA5 and hepatocellular carcinoma.